BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Deals

  Quest Diagnostics Inc. Completes Sale of HemoCue Business to Radiometer Medical ApS

  April 10, 2013

   · 

  1 min read
• Drug Development

  Patrys Limited Completes Treatment of Second Patient Group in Multiple Myeloma Trial

  April 10, 2013

   · 

  3 min read
• Business

  Vernalis PLC: Results for the Year Ended 31 December 2012

  April 10, 2013

   · 

  5 min read
• Astellas Pharma Canada, Inc. Introduces Myrbetriq™, a New Class of Treatment for Canadian Patients With Overactive Bladder

  April 10, 2013

   · 

  6 min read
• GW Pharmaceuticals’ Cannabinoid-Medicine Sativex® Moved to Schedule 4 of UK Drugs Act

  April 10, 2013

   · 

  5 min read
• Pharm Country

  Regentis Biomaterials Expands Clinical Study of GelrinC for Cartilage Repair

  April 10, 2013

   · 

  2 min read
• Business

  A*STAR: Australia and Singapore Join Forces to Tackle Emerging Infectious Diseases

  April 10, 2013

   · 

  12 min read
• Biotech Beach

  Andain Inc. Announces Successful 510K Tests of Its Breakthrough Miniature Disposable Insulin Pump

  April 10, 2013

   · 

  2 min read
• Pharm Country

  Inovio Pharmaceuticals and US Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device

  April 10, 2013

   · 

  6 min read
• Drug Development

  SALVAT and Kwang Dong Pharmaceutical Announced Positive Results of Phase IIb for Tarafenacin for Overactive Bladder Treatment

  April 10, 2013

   · 

  2 min read